Showing results (191-200 of 256) with videos related to

Sort By:
Pageof 26
British Journal of Cancer|March 1, 1995
The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancerM J Lind, L Gumbrell, B M Cantwell, et al.
Critical Reviews in Toxicology|November 4, 2020
An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpetVirunya S Bhat, Samuel M Cohen, Elliot B Gordon, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 16, 2013
Tri-diketopyrrolopyrrole molecular donor materials for high-performance solution-processed bulk heterojunction solar cellsJianhua Liu, Yanming Sun, Preecha Moonsin, et al.
Cancer Treatment Reviews|January 1, 1993
Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic resultsA H Calvert, M J Lind, M M Millward, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
British Journal of Pharmacology|September 12, 2003
Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonistThiruma V Arumugam, Naomi Arnold, Lavinia M Proctor, et al.
Plos One|August 18, 2021
Validation of a direct-to-PCR COVID-19 detection protocol utilizing mechanical homogenization: A model for reducing resources needed for accurate testingZachary P Morehouse, Lyson Samikwa, Caleb M Proctor, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancerM J Millward, D R Newell, K Yuen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481)M J Millward, D R Newell, V Mummaneni, et al.
International Journal of Cancer|October 26, 2007
Promoter hypermethylation in circulating blood cells identifies prostate cancer progressionMorgan Rouprêt, Vincent Hupertan, James W F Catto, et al.
Pageof 26